HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Herbert B. Ward Rosemary F. Kelly Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adabag, A. S. Articles by Bloomfield, H. E. Search for Related Content PubMed PubMed Citation Articles by Adabag, A. S. Articles by Bloomfield, H. E. Related Collections Coronary disease

Ann Thorac Surg 2007;83:1744-1750
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Prognostic Significance of Elevated Cardiac Troponin I After Heart Surgery

^a Division of Cardiology, Veterans Affairs Medical Center and the University of Minnesota, Minneapolis, Minnesota
^b Division of Cardiovascular Surgery, Veterans Affairs Medical Center and the University of Minnesota, Minneapolis, Minnesota
^c Center for Chronic Disease Outcomes Research, Veterans Affairs Medical Center and the University of Minnesota, Minneapolis, Minnesota

Accepted for publication December 29, 2006.

^_* Address correspondence to Dr Adabag, Veterans Affairs Medical Center, Section of Cardiology (111 C), One Veterans Dr, Minneapolis, MN 55417 (Email: adaba001{at}umn.edu).

Background: Cardiac troponin I (cTnI) measured after heart surgery has been associated with operative mortality. We sought to determine whether measuring cTnI after heart surgery provides additional prognostic information beyond that provided by validated preoperative risk scores, the Veterans Affairs (VA) risk score and the European System for Cardiac Operative Risk Evaluation (EuroSCORE).

Methods: We retrospectively collected cTnI levels measured 24 hours after surgery in 1,186 patients who underwent coronary artery bypass graft surgery (n = 696) or valve surgery (n = 490). The outcomes were operative death and perioperative myocardial infarction. The ability of the cTnI and the risk scores to discriminate patients who did or did not have the study outcomes was assessed by the area under the receiver operating curve (c-index).

Results: Mean age was 66 ± 10 years. Median cTnI was 38 ng/mL after valve surgery versus 18 ng/mL after coronary artery bypass graft surgery (p < 0.0001). There were 51 operative deaths (4.3%) and 142 perioperative myocardial infarctions (12%). For every 50 ng/mL increase in cTnI, the odds of operative death increased by 40% (odds ratio, 1.4; 95% confidence interval: 1.2 to 1.6) after coronary artery bypass graft surgery and by 30% (odds ratio, 1.3; 95% confidence interval: 1.1 to 1.5) after valve surgery. Cardiac troponin I was a significant independent correlate of perioperative myocardial infarction and death (p < 0.0001) with a c-index of 0.70 for death. Addition of cTnI improved the c-indexes of the risk scores for predicting death (from 0.75 to 0.79 for the VA risk score; p = 0.1; and from 0.69 to 0.77 for the EuroSCORE; p = 0.005).

Conclusions: Postoperative cTnI measured 24 hours after heart surgery is independently associated with operative death and perioperative myocardial infarction and improves the ability to predict operative mortality in comparison with preoperative risk scores alone.

This article has been cited by other articles:

				G. A. Lurati Buse, M. T. Koller, M. Grapow, D. Bolliger, M. Seeberger, and M. Filipovic The prognostic value of troponin release after adult cardiac surgery -- a meta-analysis Eur. J. Cardiothorac. Surg., February 1, 2010; 37(2): 399 - 406. [Abstract] [Full Text] [PDF]

				J. M. Martinez-Comendador, J. R. Alvarez, I. Mosquera, J. Sierra, B. Adrio, J. G. Carro, A. Fernandez, and J. Bengochea Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery Eur. J. Cardiothorac. Surg., December 1, 2009; 36(6): 998 - 1005. [Abstract] [Full Text] [PDF]

				G. A. Lurati Buse, M. T. Koller, M. Grapow, C. M. Bruni, J. Kasper, M. D. Seeberger, and M. Filipovic 12-month outcome after cardiac surgery: prediction by troponin T in combination with the European system for cardiac operative risk evaluation. Ann. Thorac. Surg., December 1, 2009; 88(6): 1806 - 1812. [Abstract] [Full Text] [PDF]

				A. A. Mohammed, A. K. Agnihotri, R. R.J. van Kimmenade, A. Martinez-Rumayor, S. M. Green, R. Quiroz, and J. L. Januzzi Jr Prospective, Comprehensive Assessment of Cardiac Troponin T Testing After Coronary Artery Bypass Graft Surgery Circulation, September 8, 2009; 120(10): 843 - 850. [Abstract] [Full Text] [PDF]

				J. D. Muehlschlegel, T. E. Perry, K.-Y. Liu, L. Nascimben, A. A. Fox, C. D. Collard, E. G. Avery, S. F. Aranki, M. N. D'Ambra, S. K. Shernan, et al. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting Eur. Heart J., July 1, 2009; 30(13): 1574 - 1583. [Abstract] [Full Text] [PDF]

				L. Petaja, M. Salmenpera, K. Pulkki, and V. Pettila Biochemical Injury Markers and Mortality After Coronary Artery Bypass Grafting: A Systematic Review. Ann. Thorac. Surg., June 1, 2009; 87(6): 1981 - 1992.e3. [Abstract] [Full Text] [PDF]

				V. Aboyans, M. Frank, P. Lacroix, and M. Laskar Reply to Apostolakis et al. Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 746 - 747. [Full Text] [PDF]

				J. E. Tcheng, I. H. Lim, S. Srinivasan, J. Jozic, C. M. Gibson, J. C. O'Shea, J. A. Puma, and D. I. Simon Stent Parameters Predict Major Adverse Clinical Events and the Response to Platelet Glycoprotein IIb/IIIa Blockade: Findings of the ESPRIT Trial Circ Cardiovasc Interv, February 1, 2009; 2(1): 43 - 51. [Abstract] [Full Text] [PDF]